Showing results (781-790 of 818) with videos related to

Sort By:
Pageof 82
Journal of Gastroenterology and Hepatology|May 12, 2021
Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: A real-world effectiveness analysisYuan-Jie Ding, Chung-Kuang Lu, Wei-Ming Chen, et al.
Cell Reports. Medicine|February 19, 2025
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumorsXiao-Li Wei, Hao-Xiang Wu, Dan-Yun Ruan, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 12, 2007
[Study on the variations of hepatitis B virus status among people having received hepatitis B vaccine]Li-Ping Shen, Jin-Ye Yang, Zhao-Jun Mo, et al.
Cell Reports|August 1, 2019
CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 RegulationChang Jiang, Stephen J Trudeau, Taek-Chin Cheong, et al.
International Journal of Molecular Sciences|September 7, 2016
Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric CancerCheng-Shyong Wu, Kuo-Liang Wei, Jian-Liang Chou, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|November 1, 2007
[Variations of hepatitis B virus infection epidemic pattern after long-term HBV vaccine immunization]Li-Ping Shen, Jin-Ye Yang, Zhao-Jun Mo, et al.
Scientific Reports|June 30, 2021
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in TaiwanKao-Chi Chang, Shui-Yi Tung, Kuo-Liang Wei, et al.
Cell Metabolism|July 2, 2019
Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell TransformationLiang Wei Wang, Hongying Shen, Luis Nobre, et al.
Pageof 82